{"transactions":[{"id":3796014,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T16:37:31.000Z","date":"2018-10-04","kind":"purchase","acquired":true,"shares":7100,"price":13.9958,"value":99370.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.90 to $14.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":177457,"source":{"system":"sec-edgar","filing":"0001209191-18-054397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118054397/doc4.xml","form_type":"4"}},{"id":3832818,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T16:46:21.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":6600,"price":14.9977,"value":98984.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018."}],"balance_after":170357,"source":{"system":"sec-edgar","filing":"0001209191-18-048503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118048503/doc4.xml","form_type":"4"}},{"id":3840209,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T16:55:40.000Z","date":"2018-08-15","kind":"purchase","acquired":true,"shares":6250,"price":15.97,"value":99812.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.93 to $16.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":163757,"source":{"system":"sec-edgar","filing":"0001209191-18-047417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118047417/doc4.xml","form_type":"4"}},{"id":3966979,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-09T16:50:58.000Z","date":"2018-04-06","kind":"purchase","acquired":true,"shares":26700,"price":16.54,"value":441618.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.23 to $17.06, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":157507,"source":{"system":"sec-edgar","filing":"0001209191-18-024356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118024356/doc4.xml","form_type":"4"}},{"id":3987676,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-20T17:03:49.000Z","date":"2018-03-16","kind":"other","acquired":true,"shares":9018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by NST, LLC, of which the reporting person is a member and the sole Manager, in accordance with NST, LLC's Limited Liability Company Operating Agreement."}],"balance_after":130807,"source":{"system":"sec-edgar","filing":"0001209191-18-020924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118020924/doc4.xml","form_type":"4"}},{"id":3987675,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-20T17:03:49.000Z","date":"2018-03-16","kind":"other","acquired":false,"shares":94151,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NST, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by NST, LLC, of which the reporting person is a member and the sole Manager, in accordance with NST, LLC's Limited Liability Company Operating Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares were held by NST, LLC of which the reporting person is a member and the sole Manager. The reporting person had sole voting and dispositive power over the shares held by NST, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-020924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919118020924/doc4.xml","form_type":"4"}},{"id":4600122,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T19:08:35.000Z","date":"2016-09-15","kind":"other","acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pro rata distribution by NST, LLC, of which the reporting person is a member, in accordance with NST, LLC's Limited Liability Company Operating Agreement.  NST, LLC received 144,153 shares of the issuer's common stock as a liquidating distribution from NeXeption, LLC described in footnotes (1) and (2) above and immediately distributed 50,002 of the shares on a pro rata basis to its members."}],"balance_after":121789,"source":{"system":"sec-edgar","filing":"0001209191-16-142071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919116142071/doc4.xml","form_type":"4"}},{"id":4600121,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T19:08:35.000Z","date":"2016-09-15","kind":"other","acquired":false,"shares":50002,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NST, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pro rata distribution by NST, LLC, of which the reporting person is a member, in accordance with NST, LLC's Limited Liability Company Operating Agreement.  NST, LLC received 144,153 shares of the issuer's common stock as a liquidating distribution from NeXeption, LLC described in footnotes (1) and (2) above and immediately distributed 50,002 of the shares on a pro rata basis to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by NST, LLC of which the reporting person is a member and the sole Manager.  The reporting person has sole voting and dispositive power over the shares held by NST, LLC.  The reporting person disclaims beneficial ownership over the shares held by NST, LLC except to the extent of his pecuniary interest therein."}],"balance_after":94151,"source":{"system":"sec-edgar","filing":"0001209191-16-142071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919116142071/doc4.xml","form_type":"4"}},{"id":4600120,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T19:08:35.000Z","date":"2016-09-15","kind":"other","acquired":true,"shares":144153,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NST, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Liquidating distribution by NeXeption, LLC, of which the reporting person is a member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement. The reporting person was also the sole Manager of NeXeption, LLC prior to its liquidation.  In prior reports, the reporting person reported beneficial ownership of 521,739 shares of the issuer's common stock held by NeXeption, LLC.  The reporting person disclaims beneficial ownership of the shares held by NeXeption, LLC except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by NST, LLC of which the reporting person is a member and the sole Manager.  The reporting person has sole voting and dispositive power over the shares held by NST, LLC.  The reporting person disclaims beneficial ownership over the shares held by NST, LLC except to the extent of his pecuniary interest therein."}],"balance_after":144153,"source":{"system":"sec-edgar","filing":"0001209191-16-142071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919116142071/doc4.xml","form_type":"4"}},{"id":4600119,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T19:08:35.000Z","date":"2016-09-15","kind":"other","acquired":true,"shares":116999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Liquidating distribution by NeXeption, LLC, of which the reporting person is a member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement. The reporting person was also the sole Manager of NeXeption, LLC prior to its liquidation.  In prior reports, the reporting person reported beneficial ownership of 521,739 shares of the issuer's common stock held by NeXeption, LLC.  The reporting person disclaims beneficial ownership of the shares held by NeXeption, LLC except to the extent of his pecuniary interest therein."}],"balance_after":116999,"source":{"system":"sec-edgar","filing":"0001209191-16-142071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919116142071/doc4.xml","form_type":"4"}},{"id":4600118,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":163157,"kind":"person","name":"Tullman Stephen A.","position":1,"cik":"0001654343","reported_name":"Tullman Stephen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T19:08:35.000Z","date":"2016-09-15","kind":"other","acquired":false,"shares":521739,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NeXeption, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Liquidating distribution by NeXeption, LLC, of which the reporting person is a member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement. The reporting person was also the sole Manager of NeXeption, LLC prior to its liquidation.  In prior reports, the reporting person reported beneficial ownership of 521,739 shares of the issuer's common stock held by NeXeption, LLC.  The reporting person disclaims beneficial ownership of the shares held by NeXeption, LLC except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Liquidating distribution by NeXeption, LLC, of which the reporting person is a member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement. The reporting person was also the sole Manager of NeXeption, LLC prior to its liquidation.  In prior reports, the reporting person reported beneficial ownership of 521,739 shares of the issuer's common stock held by NeXeption, LLC.  The reporting person disclaims beneficial ownership of the shares held by NeXeption, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-142071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654343/000120919116142071/doc4.xml","form_type":"4"}}]}